[{"data": {"name": "High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liv", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Adarsh S. Gandhi", "@type": "Person"}, {"name": "Ariane Wohlfarth", "@type": "Person"}, {"name": "Mingshe Zhu", "@type": "Person"}, {"name": "Shaokun Pang", "@type": "Person"}, {"name": "Marisol Castaneto", "@type": "Person"}, {"name": "Karl B. Scheidweiler", "@type": "Person"}, {"name": "Marilyn A. Huestis", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4232487?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Wiley-Blackwell", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1002/dta.1662", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCVTFi9RuBeoe-CTMhcqCodJJsw-CDVbMzymM7TVc-CRvYwXbMaL86Y", "propertyID": "ISCC"}], "datePublished": "2014-05-14"}, "schema": "schema.org", "mediatype": "application/ld+json"}]